T/R potency <5% [Regulatives / Guidelines]

posted by Achievwin – US, 2022-09-07 20:22 (459 d 11:41 ago) – Posting: # 23275
Views: 2,491

Colleagues:

Somewhere in the Bioequivalence guidance I remembered that when designing the studies we try to keep T/R potency +/-5%. Can someone point out where this kind of condition existed, (latest guidance has no mention of this)

Thanks in advance for your guidance,

Complete thread:

UA Flag
Activity
 Admin contact
22,823 posts in 4,786 threads, 1,632 registered users;
29 visitors (0 registered, 29 guests [including 7 identified bots]).
Forum time: 07:04 CET (Europe/Vienna)

In these matters the only certainty is
that nothing is certain.    Pliny the Elder

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5